Finance

Lists
000623:SHE
Jilin Aodong Pharmaceutical Group Co Ltd
CNÂ¥18.29
+0.66%
(+0.12) 1D
Sep 8, 3:04:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000623...
Open
CNÂ¥18.22
High
CNÂ¥18.34
Low
CNÂ¥18.18
Mkt. cap
22.11B
Avg. vol.
12.79M
Volume
7.32M
Dividend
2.73%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jul 8, 2026
P/E ratio
6.78
52-wk high
CNÂ¥22.08
52-wk low
CNÂ¥16.36
EPS
CNÂ¥2.70
Shares outstanding
1.20B
No. of employees
5K
Open
CNÂ¥18.22
High
CNÂ¥18.34
Low
CNÂ¥18.18
Mkt. cap
22.11B
Avg. vol.
12.79M
Volume
7.32M
Dividend
2.73%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jul 8, 2026
P/E ratio
6.78
52-wk high
CNÂ¥22.08
52-wk low
CNÂ¥16.36
EPS
CNÂ¥2.70
Shares outstanding
1.20B
No. of employees
5K
Profile
Jilin Aodong Medicine Industry Group Company Limited is a state-owned enterprise in Dunhua, Jilin, China. It involves in the manufacture and sale of Chinese patent drugs and pharmaceutical packaging products, and the collection of traffic tolls and the road engineering construction business. It was established in 1993 and listed on the Shenzhen Stock Exchange in 1996. Wikipedia
About Jilin Aodong Pharmaceutical Group Co Ltd
CEO-
Employees5.05K
FoundedMar 20, 1993
Headquarters-
SectorPharmaceutical industry
Websitejlaod.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
513.94M
694.88M
514.09M
516.91M
Cost of goods sold
277.23M
401.66M
265.19M
285.23M
Cost of revenue
277.23M
401.66M
265.19M
285.23M
Research and development expenses
20.32M
50.31M
14.36M
14.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
217.18M
375.32M
194.13M
204.97M
Operating expense
213.20M
462.78M
225.97M
230.21M
Total operating expenses
490.43M
864.44M
491.16M
515.45M
Operating income
23.51M
-169.57M
22.94M
1.46M
Other non operating income
8.50M
-11.31M
-653.65K
1.59M
EBT including unusual items
1.02B
76.89M
865.54M
1.14B
EBT excluding unusual items
881.21M
310.73M
905.90M
1.31B
Income tax expense
46.89M
-29.05M
446.06K
-39.10M
Effective tax rate
4.58%
-37.77%
0.05%
-3.42%
Other operating expenses
-17.06M
38.39M
10.48M
10.49M
Net income
978.96M
134.74M
866.00M
1.18B
Net profit margin
190.48%
19.39%
168.45%
229.06%
Earnings per share
-
-
-
-
Interest and investment income
865.41M
507.32M
898.86M
1.31B
Interest expense
-16.21M
-15.71M
-15.25M
-6.62M
Net interest expenses
849.20M
491.61M
883.61M
1.31B
Depreciation and amortization charges
-
-
-
-
EBITDA
74.98M
-121.80M
70.71M
44.84M
Gain or loss from assets sale
127.66K
-1.32M
-
4.80M
AI content may include mistakes. Learn more
Google apps